2022
DOI: 10.1016/j.jddst.2022.103491
|View full text |Cite
|
Sign up to set email alerts
|

Posaconazole-amino acid cocrystals for improving solubility and oral bioavailability while maintaining antifungal activity and low In vivo toxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…The cocrystals with 4aminobenzoic acid, L-glutamine, and L-asparagine are the only three examples of posaconazole cocrystals reported in the literature. 4,36 However, several cocrystals of itraconazole, which is structurally similar to posaconazole, with dicarboxylic acids are known. 47,48 cocrystal screening for PSZ could reveal new multicomponent crystalline forms of the compound.…”
Section: ■ Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The cocrystals with 4aminobenzoic acid, L-glutamine, and L-asparagine are the only three examples of posaconazole cocrystals reported in the literature. 4,36 However, several cocrystals of itraconazole, which is structurally similar to posaconazole, with dicarboxylic acids are known. 47,48 cocrystal screening for PSZ could reveal new multicomponent crystalline forms of the compound.…”
Section: ■ Resultsmentioning
confidence: 99%
“…The cocrystals with 4-aminobenzoic acid, l -glutamine, and l -asparagine are the only three examples of posaconazole cocrystals reported in the literature. , However, several cocrystals of itraconazole, which is structurally similar to posaconazole, with dicarboxylic acids are known. , This information suggested that a cocrystal screening for PSZ could reveal new multicomponent crystalline forms of the compound. To test this hypothesis, we screened potential coformers, including acidic and neutral compounds, by combining the mentioned computational tools with high-throughput screening experiments (Figure ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Several methods have been established to address this concern, including the use of prodrugs [ 1 , 2 , 3 , 4 , 5 ], nanosuspensions, [ 6 , 7 , 8 , 9 ] or complexation of APIs [ 10 , 11 , 12 , 13 , 14 ], and modification of the solid API phase itself. The latter approach can be achieved through the formation of API salts, co-crystals, or amorphous systems to enhance the targeted drug’s solubility properties [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 ]. Product solubility is influenced by various thermodynamic and kinetic factors, such as the solubilities of the co-formers, solvent environment, and molecular characteristics like polarization or ionization [ 17 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%